SNPS

Synopsys, Inc.

NASDAQ • USD • TECHNOLOGY • SOFTWARE - INFRASTRUCTURE

Current Price $455.51 6 Months: -0.57%

52-Week Range

$376.18 $651.73

Current price is 28.8% of 52-week range

Key Metrics

Market Cap $95.4B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $19.47
Beta 1.2
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate 8.52%

AI Overview

Last updated 11 days ago

Synopsys has a durable moat in EDA and semiconductor IP, where switching costs, deep customer integration, and long design cycles create sticky, subscription-like revenue. AI-driven silicon complexity and leading-edge nodes (e.g., 2nm flows) are sustaining tool demand, while partnerships like the expanded NVIDIA collaboration and work with Arm reinforce relevance across the full design stack. The Ansys combination broadens the platform into multiphysics simulation, strengthening the “silicon-to-systems” value proposition, though integration execution remains key.

Financially, results show strong scale but noisy GAAP profitability due to acquisition-related amortization and costs: Q2 FY26 revenue was $2.276B with GAAP EPS of $0.09 and non-GAAP EPS of $3.35, and management raised FY26 non-GAAP EPS guidance to $14.76 at the midpoint. Q1 FY26 revenue was $2.409B with non-GAAP EPS of $3.77, indicating sustained earnings power on a non-GAAP basis. Balance-sheet detail is limited here, but third-party data indicates elevated long-term debt post-deal and expanded share count, which can pressure per-share compounding if growth slows.

Over the next 12 months, the core thesis is that Synopsys remains a high-quality compounder levered to AI/accelerated computing design intensity, with upside if Ansys integration delivers synergy-driven margin expansion and cross-sell traction. Catalysts include continued guide raises as Ansys contributes, accelerating bookings tied to advanced-node and AI silicon programs, and clearer long-term targets at the planned September 2026 Investor Day. Key risks are integration missteps, customer seat/IP cyclicality if semiconductor capex weakens, and valuation sensitivity given the stock’s wide 52-week range ($376–$652).

Recommendation: HOLD. Synopsys offers best-in-class strategic positioning and rising FY26 outlook, but acquisition-driven leverage/GAAP compression and likely premium valuation leave less margin of safety for new buyers at current levels.

Price & Profitability History

6 Months change: -0.57% (-$2.62)

Log in